| 483 |
66: Activation, ChREBP |
458: Increased, De Novo FA synthesis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 484 |
458: Increased, De Novo FA synthesis |
454: Increased, Triglyceride formation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 486 |
454: Increased, Triglyceride formation |
459: Increase, Liver steatosis |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 487 |
228: demethylation, PPARg promoter |
457: Activation, SREBF1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 489 |
457: Activation, SREBF1 |
462: Up Regulation, SCD-1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 490 |
167: Activation, LXR |
463: Up Regulation, FAS |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 491 |
167: Activation, LXR |
462: Up Regulation, SCD-1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 492 |
463: Up Regulation, FAS |
458: Increased, De Novo FA synthesis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 493 |
462: Up Regulation, SCD-1 |
454: Increased, Triglyceride formation |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 495 |
18: Activation, AhR |
54: Up Regulation, CD36 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 496 |
18: Activation, AhR |
465: Increased, FA Influx |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 499 |
18: Activation, AhR |
216: Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 501 |
54: Up Regulation, CD36 |
465: Increased, FA Influx |
Nov 29, 2016 |
Dec 3, 2016 |
3 AOPs
|
| 503 |
216: Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway) |
327: Accumulation, Fatty acid |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 504 |
465: Increased, FA Influx |
291: Accumulation, Triglyceride |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 505 |
465: Increased, FA Influx |
327: Accumulation, Fatty acid |
Nov 29, 2016 |
Dec 3, 2016 |
3 AOPs
|
| 506 |
18: Activation, AhR |
466: Up Regulation, LDLR (low density lipoprotein receptor) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 507 |
466: Up Regulation, LDLR (low density lipoprotein receptor) |
467: Increased, LDL uptake |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 508 |
467: Increased, LDL uptake |
327: Accumulation, Fatty acid |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 509 |
18: Activation, AhR |
450: Decrease, VLDL export capacity |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 510 |
167: Activation, LXR |
468: Inhibition, PPAR alpha |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 511 |
468: Inhibition, PPAR alpha |
451: Inhibition, Mitochondrial fatty acid beta-oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 512 |
458: Increased, De Novo FA synthesis |
327: Accumulation, Fatty acid |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 514 |
327: Accumulation, Fatty acid |
454: Increased, Triglyceride formation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 515 |
327: Accumulation, Fatty acid |
459: Increase, Liver steatosis |
Nov 29, 2016 |
Dec 3, 2016 |
4 AOPs
|